JP7851528B2 - クロストリジウム パーフリンジェンスの芽胞形成抑制剤 - Google Patents

クロストリジウム パーフリンジェンスの芽胞形成抑制剤

Info

Publication number
JP7851528B2
JP7851528B2 JP2023533142A JP2023533142A JP7851528B2 JP 7851528 B2 JP7851528 B2 JP 7851528B2 JP 2023533142 A JP2023533142 A JP 2023533142A JP 2023533142 A JP2023533142 A JP 2023533142A JP 7851528 B2 JP7851528 B2 JP 7851528B2
Authority
JP
Japan
Prior art keywords
oil
inorganic compound
spore formation
formation inhibitor
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023533142A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023282255A5 (https=
JPWO2023282255A1 (https=
Inventor
章敬 上原
康晃 坂元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of JPWO2023282255A1 publication Critical patent/JPWO2023282255A1/ja
Publication of JPWO2023282255A5 publication Critical patent/JPWO2023282255A5/ja
Application granted granted Critical
Publication of JP7851528B2 publication Critical patent/JP7851528B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/22—Compounds of alkali metals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2023533142A 2021-07-07 2022-07-05 クロストリジウム パーフリンジェンスの芽胞形成抑制剤 Active JP7851528B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021112772 2021-07-07
JP2021112772 2021-07-07
PCT/JP2022/026692 WO2023282255A1 (ja) 2021-07-07 2022-07-05 クロストリジウム パーフリンジェンスの芽胞形成抑制剤

Publications (3)

Publication Number Publication Date
JPWO2023282255A1 JPWO2023282255A1 (https=) 2023-01-12
JPWO2023282255A5 JPWO2023282255A5 (https=) 2025-07-02
JP7851528B2 true JP7851528B2 (ja) 2026-04-27

Family

ID=84800649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023533142A Active JP7851528B2 (ja) 2021-07-07 2022-07-05 クロストリジウム パーフリンジェンスの芽胞形成抑制剤

Country Status (5)

Country Link
US (1) US20240225053A9 (https=)
EP (1) EP4368031A4 (https=)
JP (1) JP7851528B2 (https=)
CN (1) CN117642171A (https=)
WO (1) WO2023282255A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005536201A (ja) 2002-07-12 2005-12-02 ビーエーエスエフ アクチェンゲゼルシャフト 少なくとも１種の二ギ酸塩を含有する調製物
JP2010110321A (ja) 2008-10-09 2010-05-20 Ito En Ltd 有芽胞菌の芽胞発芽増殖阻害剤及び有芽胞菌の芽胞発芽増殖阻害方法
JP2015511125A (ja) 2012-02-07 2015-04-16 ダニスコ・ユーエス・インク フィチン酸によるフィターゼの安定性の改良、並びにフィターゼ及びフィチン酸を含む組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0413645B1 (pt) * 2003-09-05 2014-08-05 Hills Pet Nutrition Inc Composição para o consumo animal, processo para a produção da mesma
JP2017517484A (ja) * 2014-03-31 2017-06-29 イオテック インターナショナル， インコーポレイテッド 非錯体化ヨウ素の安定な組成物及び使用方法
TWI569802B (zh) 2014-07-17 2017-02-11 國立成功大學 氧化鐵奈米粒子於抑制困難梭狀芽孢桿菌之孢子發芽的用途
BR112020018621A2 (pt) 2018-03-16 2020-12-29 Ajinomoto Co., Inc. Composição de aditivo de ração de tipo revestido, ração, e, uso de um agente revestido .
CN118265455A (zh) * 2021-11-22 2024-06-28 帝斯曼奥地利有限责任公司 用于调节微生物生长的组合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005536201A (ja) 2002-07-12 2005-12-02 ビーエーエスエフ アクチェンゲゼルシャフト 少なくとも１種の二ギ酸塩を含有する調製物
JP2010110321A (ja) 2008-10-09 2010-05-20 Ito En Ltd 有芽胞菌の芽胞発芽増殖阻害剤及び有芽胞菌の芽胞発芽増殖阻害方法
JP2015511125A (ja) 2012-02-07 2015-04-16 ダニスコ・ユーエス・インク フィチン酸によるフィターゼの安定性の改良、並びにフィターゼ及びフィチン酸を含む組成物

Also Published As

Publication number Publication date
EP4368031A4 (en) 2025-07-16
US20240130403A1 (en) 2024-04-25
EP4368031A1 (en) 2024-05-15
US20240225053A9 (en) 2024-07-11
JPWO2023282255A1 (https=) 2023-01-12
BR112023026526A2 (pt) 2024-03-05
WO2023282255A1 (ja) 2023-01-12
CN117642171A (zh) 2024-03-01

Similar Documents

Publication Publication Date Title
JP6991162B2 (ja) プロバイオティック活性を示すバチルス・サブティリス（Ｂａｃｉｌｌｕｓ ｓｕｂｔｉｌｉｓ）菌株
Mahesh et al. Probiotics in livestock and poultry nutrition and health
Asml et al. The beneficial role of probiotics in monogastric animal nutrition and health
TWI794174B (zh) 具有益生菌活性之枯草桿菌（Ｂａｃｉｌｌｕｓ ｓｕｂｔｉｌｉｓ）菌株
KR20150039816A (ko) 사료 첨가제 조성물
CN114615894B (zh) 包含乳杆菌菌株组合的用于消化道健康的组合物
JP2020525034A (ja) プロバイオティクス活性がある枯草菌株
JP2019522468A (ja) プロバイオティック活性を示すバチルス・リケニフォルミス（Ｂａｃｉｌｌｕｓ ｌｉｃｈｅｎｉｆｏｒｍｉｓ）菌株
US20250090603A1 (en) Compositions containing bacillaene producing bacteria or preparations thereof
Stadnicka et al. Poultry science: The many faces of chemistry in poultry production and processing
EP3840585A1 (en) Improved animal feed product
KR100923226B1 (ko) 항균효과가 강화된 사료첨가용 유산균제제 와 그 제조방법
EP4130258A1 (en) Microorganisms displaying viral decoy receptors
JP7851528B2 (ja) クロストリジウム パーフリンジェンスの芽胞形成抑制剤
WO2022169933A2 (en) Compositions for gut health
BR112023026526B1 (pt) Inibidor de esporulação de clostridium perfringens, suplemento para prevenir ou tratar infecção por clostridium perfringens, e, alimento
TW201809264A (zh) 具有益生菌活性之地衣芽孢桿菌（Ｂａｃｉｌｌｕｓ ｌｉｃｈｅｎｉｆｏｒｍｉｓ）菌株
RU2846511C2 (ru) Композиции для поддержания здорового состояния кишечника, содержащие комбинации штаммов lactobacillus
Rajendran Role of Probiotics on Animal Nutrition and Health
TW201715038A (zh) 新穎的根特節桿菌（ａｒｔｈｒｏｂａｃｔｅｒ ｇａｎｄａｖｅｎｓｉｓ ｓｔｒａｉｎｓ）菌株
McElroy The Effects of Dietary Calcium and Enzyme Supplementation on the Occurrence of Necrotic Enteritis Diego Moreira Paiva
Vilà i Miquel et al. Application of ZnO-Functionalised-Sepiolite in weaning piglet diets
Paiva Effects of Calcium and Enzyme Supplementation on the Occurrence of Necrotic Enteritis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250624

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250624

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260316

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260329

R150 Certificate of patent or registration of utility model

Ref document number: 7851528

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150